Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 4Melanoma 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Smoking Cessation 1Nose Neoplasms 1Neoplasms 1Multiple Pulmonary Nodules 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Liver Cirrhosis 1Esthesioneuroblastoma, Olfactory 1Esophageal Neoplasms 1Endometrial Neoplasms 1Cancer Diagnosis 1Burkitt Lymphoma 1Biliary Tract Neoplasms 1

Interventions

tremelimumab 1fluoromisonidazole 1epigallocatechin gallate 1durvalumab 1Ultrasonography 1Tomography, X-Ray Computed 1Tomography 1Positron-Emission Tomography 1Everolimus 1Erlotinib Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Liver Cirrhosis × Positron-Emission Tomography × Clear all
NCT02695628 2024-01-31

[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer

Stanford University

Phase 2 Completed
5 enrolled 8 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡